Sequential hormone-chemotherapy (MAP at high doses and CMF) in metastatic breast cancer. Preliminary results
Pannuti, F.; Di Marco, A.R.; Rossi, A.P.; Rocchetta, G.; Rubino, I.; Giovannini, M.; Fruet, F.
Panminerva Medica 23(2): 93-96
1981
ISSN/ISBN: 0031-0808 PMID: 6459563 Document Number: 170996
Document emailed within 1 workday
Related Documents
Pannuti, F.; Rossi, A.P.; Di Marco, A.R.; Fruet, F.; Lelli, G.; Strocchi, E.; Rocchetta, G.; Piana, E.; Martoni, A. 1981: Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study Panminerva Medica 23(1): 25-28Manni, A.; Trujillo, J.E.; Pearson, O.H. 1980: Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival Cancer Treatment Reports 64(1): 111-116
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Leonard, R.C. 1998: High-dose chemotherapy in metastatic breast cancer Lancet 351(9107): 986
Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Seminars in Oncology 23(1 Suppl 2: 60-67
Bacci, G.; Picci, P.; Ruggieri, P.; Avella, M.; Mercuri, M.; Capanna, R.; Biagini, R.; Tienghi, C.; Mancini, A.; Brach del Prever, A. 1991: Neoadjuvant chemotherapy for the treatment of osteosarcoma of the limbs. Preliminary results in 100 patients treated preoperatively with high doses of methotrexate I.v. followed by cisplatin (i.a.) and adriamycin La Chirurgia Degli Organi di Movimento 76(1): 1-16
Stemmler, H.J.; Salat, C.; Lindhofer, H.; Menzel, H.; Untch, M.; Kahlert, S.; Konecny, G.; Sauer, H.; Ledderose, G.; Heinemann, V.; Kolb, H.J. 2005: Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study Anticancer Research 25(4): 3047-3054
Lück, H.J.; Thomssen, C.; du Bois, A.; Lisboa, B.W.; Untch, M.; Kühnle, H.; Jänicke, F.; Meerpohl, H.G.; Lindner, C.; Konecny, G.; Hecker, D.; Diergarten, K. 1997: Preliminary results of a phase Ii study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer Seminars in Oncology 24(1 Suppl 3: S13-S16
Kubota, O.; Onuki, Y.; Uchiyama, T.; Oishi, K.; Takeda, M. 2012: Efficacy of high-dose toremifene as a second-line hormone therapy in patients with advanced or metastatic breast cancer resistant to aromatase inhibitor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 753-757
Solano, C.; Sola, C.; Lluch, A.; Hornedo, J.; López, J.; Cortés-Funes, H.; García-Conde, J. 1997: High-dosage chemotherapy and autologous transplant of hematopoietic germ cells from peripheral blood in high-risk recurrence carcinoma of the breast (with >= or 10 involved axillary nodes at diagnosis) Preliminary results of the Solti 9301 cooperative study Sangre 42(Suppl 1): 53-56
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Guarnieri, A.; Tucci, E.; D'Aniello, C.; Carli, A.; Mariani, L.; De Stefano, A.; Nardi, P. 1984: Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(5): 320-323
Koyama, H.; Iesato, A.; Fukushima, Y.; Okada, T.; Watanabe, T.; Harada, M.; Ito, T.; Maeno, K.; Mochizuki, Y.; Ito, K.; Amano, J. 2011: A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(7): 1123-1126
Ohtake, T.; Yasuda, M.; Watanabe, K.; Ito, T.; Ito, J.; Miyamoto, K.; Yoshida, S.; Abe, N.; Ishigame, T.; Ishii, M.; Kimijima, I.; Takenoshita, S. 2009: Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1459-1463
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Altundag, K. 2018: Concurrent administration of aromatase inhibitors with chemotherapy might show better outcome in high risk hormone-receptor positive early-stage breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1559-1560
Gebbia, V.; Caruso, M.; Borsellino, N.; Ajello, R.; Tirrito, M.Lina.; Chiarenza, M.; Valenza, R.; Verderame, F.; Varvara, F.; Marrazzo, A.; Bajardi, E.; Ferrao, F.; Bordonaro, R.; Tralongo, P. 2006: Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM) Anticancer Research 26(4b): 3143-3150
Vici, P.; Foggi, P.; Colucci, G.; Capomolla, E.; Brandi, M.; Giotta, F.; Gebbia, N.; Di Lauro, L.; Valerio, M.Rosaria.; Paoletti, G.; Belli, F.; Pizza, C.; Giannarelli, D.; Lopez, M. 2005: Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer Anticancer Research 25(2b): 1309-1314
Tashiro, H. 2000: Standard chemotherapy for metastatic breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 246-253
Pannuti, F.; Martoni, A.; Piana, E.; Tomasi, L.; Grieco, A.; Farris, A.; Saccani, F.; Baroni, M. 1984: Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(4): 211-215